A cosmid library from Mycobacterium tuberculosis H37Ra was introduced into Mycobacterium smegmatis, and eight recombinant clones with increased resistance to cefoxitin were identified. Isoelectric focusing detected an M. tuberculosis-derived ␤-lactamase in one of these recombinant clones. A sequence analysis identified it as a class A ␤-lactamase whose expression correlated with the increased resistance phenotype.
155 or E. coli 2319 was with kanamycin. (M. smegmatis mc 2 155 and E. coli 2319 were both kindly provided by Lolita Ramakrishna.) E. coli DH5␣ (Gibco-BRL, Gaithersburg, Md.) and pBluescript SK Ϫ (Stratagene, San Diego, Calif.) were used for subcloning by standard methods (24) .
A cosmid library from M. tuberculosis H37Ra was constructed with pYUB18 as previously described (13) . Briefly, genomic DNA was partially digested with Sau3AI and electrophoresed overnight in a 0.4% agarose gel. High-molecularweight fragments (35 to 45 kb) were gel purified and ligated to BamHI-digested pYUB18. The ligation mixture was packaged in vitro (Gigapack-II XL; Stratagene) according to the manufacturer's instructions except that TMGS buffer (10 mM Tris [pH 7.4]-10 mM MgSO 4 -0.1% gelatin-100 mM NaCl) (12) was used as the diluent. After transduction of E. coli 2819, purified recombinant shuttle phagemids were obtained by CsCl gradient centrifugation (24) and used for transformation of M. smegmatis mc 2 
155
. To obtain electroporation-competent bacteria, a 2-day-old culture of M. smegmatis mc 2 155 was pelleted, washed, and resuspended in 10% glycerol. One to five micrograms of the purified cosmid DNA was mixed with 50 l of competent cells in a cuvette (0.2-cm gap; Bio-Rad, Richmond, Calif.). Electroporation parameters were 25 kV, 25 F, and 1,000 ⍀, with a time constant of ϳ20 ms. The transformants were selected on plates containing 10 g of kanamycin per ml.
Approximately 3,000 transformants were obtained after electroporation of the recombinant phagemids into M. smegmatis. These 3,000 transformants and the parent strain containing only the cloning vector were replica plated onto TYM plates containing 10 g of kanamycin per ml plus 32, 64, 128, or 256 g of cefoxitin per ml. The MIC of cefoxitin for M. tuberculosis H37Ra is Ͼ16 g/ml, a value that is reduced to 8 g/ml when the ␤-lactamase inhibitor clavulanic acid is present. Because clavulanic acid has no activity of its own against M. tuberculosis (MIC Ͼ16 g/ml) (6), the resistance is most likely due to the hydrolysis of cefoxitin by the enzyme. Therefore, we hypothesized that transformants that expressed ␤-lactamase from both M. smegmatis and M. tuberculosis would show an increased resistance to cefoxitin compared to the M. smegmatis parent strain.
The parent strain and the vast majority of the recombinants were inhibited by 64 g of cefoxitin per ml. Eight colonies grew at each of the higher concentrations and were considered candidates for expression of the cloned M. tuberculosis ␤-lactamase. One of the recombinant strains, IU17, was selected for further study.
All mycobacterial ␤-lactamases investigated thus far have isoelectric points (pIs) between 4.4 and 6.0 (30) . By adjusting the ampholyte concentrations in an isoelectric focusing (IEF) gel, the IEF pattern for M. smegmatis ␤-lactamase, having pIs of 4.3 and 5.4 (18, 21, 30) , can be readily distinguished from that for the M. tuberculosis enzyme, having pIs of 4.9 and 5.1 (30, 31) . ␤-Lactamase IEF patterns from recombinant strain IU17, the M. smegmatis host, and M. tuberculosis were compared. Cell extracts were obtained as described earlier (6), and equivalent protein amounts were electrofocused for 900 V ⅐ h in a 4% acrylamide-0.125% bisacrylamide matrix containing 5% ampholytes (Biolyte 3-5; BioRad) (23) . Gels were incubated with 0.5 M nitrocefin, a chromogenic substrate of ␤-lactamase (Cefinase; BBL). The nitrocefin stain readily diffuses in this low-acrylamide matrix; therefore, the gels were observed immediately for the detection of IEF ␤-lactamase patterns from M. smegmatis or M. tuberculosis.
Recombinant strain IU17 had an IEF pattern that was a composite of the patterns found in M. tuberculosis and M. smegmatis, suggesting that it expressed a ␤-lactamase from both. ␤-Lactamase activity was not detected when the cosmid was in the E. coli host.
To localize the M. tuberculosis ␤-lactamase gene on the 36-kb insert of pIU17, BamHI-digested fragments of pIU17 were ligated to pYUB18 and reintroduced into M. smegmatis. One subclone, IU1701, exhibited increased resistance to cefoxitin and had a ␤-lactamase IEF pattern similar to that of IU17; i.e., nitrocefin-stained bands from both M. tuberculosis and M. smegmatis were present. The insert from strain IU1701 was subcloned into pBluescript for sequencing by the dideoxy chain termination reaction (25) with Sequenase 2.0 and universal primers. The sequencing of the entire gene on both strands was subsequently performed at the Biomedical Resource Center at the University of California, San Francisco.
The sequence obtained was analyzed with the University of Wisconsin Genetics Computer Group software package (8) . The amino acid sequence translated from one of the open reading frames contained the penicillin binding motifs that are found in all proteins of the penicillin binding superfamily (9) . By using the software program PILEUP, these motifs, SXXK, SDN, EXELN, and KT(S)G, were aligned with those from other class A ␤-lactamases (Fig. 1) (3) .
Interestingly, the SDN penicillin binding motif was not completely conserved in M. tuberculosis H37Ra's ␤-lactamase. Instead, this strain's motif was SDG. This was confirmed by sequencing both strands of the subcloned gene (blaA) as well as the gene on the original cosmid, IU17. To rule out a cloning artifact during the original library construction, the gene was PCR amplified from strain H37Ra's genomic DNA and subjected to cycle sequencing (AmpliCycle sequencing kit; PerkinElmer Corp., Foster City, Calif.). Again, the motif was SDG, not SDN. This change in this motif has not been identified in any other class A ␤-lactamase whose sequence has been submitted to GenBank or previously reported (3, 9) . the blaA gene from strain H37Ra [including the unusual SDG motif described above].)
Because M. smegmatis contains a ␤-lactamase whose gene has not yet been cloned (17) , the origin of blaA was verified by Southern blot hybridization (24) . Genomic DNA from M. tuberculosis and M. smegmatis (5 g) and from pIU17 (0.1 g) was restriction digested, separated by agarose gel electrophoresis, and transferred to a nylon membrane (Hybond N; Amersham). An oligonucleotide specific for the blaA gene (5Ј-GACCGGGACCGGTGACTACGG) was synthesized and 5Ј end labeled with [␥-32 P]ATP. Hybridization and washes were at high stringency, and detection was by autoradiography. Restriction-digested fragments of the same size from pIU17 and M. tuberculosis genomic DNA contained the blaA gene ( Fig. 2A) . The specific probe did not hybridize with genomic DNA from M. smegmatis, even at low stringency; thus, blaA originated from M. tuberculosis.
The M. tuberculosis genome project also identified a partial open reading frame (GenBank accession number, Z73101; gene MTCY31.35) that has similarities with class C ␤-lactamases, such as the AmpC cephalosporinases found in gramnegative organisms (3).
To assess whether the gene for this putative ␤-lactamase (blaC) is also found in strain H37Ra, an oligonucleotide derived from the blaC sequence (5Ј-CATGCGGTAACCGACA ACGT) was constructed and used as a hybridization probe for Southern blots. The blaC probe hybridized with genomic DNA from strain H37Ra but not with that from pIU17 (Fig. 2B) , indicating that the gene is also present in this strain but is not in close proximity to blaA. Just as with the blaA probe, hybridization with genomic DNA from M. smegmatis was not detected, even at low stringency. If M. smegmatis also has a blaC gene, its sequence is not very similar to that of blaC from M. tuberculosis.
It is not clear if the class C ␤-lactamase is produced by M. tuberculosis. Class C ␤-lactamases are typically poorly inhibited by clavulanic acid, yet we and others have found that ␤-lactamase activity in M. tuberculosis crude cell extracts is readily inactivated by this inhibitor (6, 30) . Also, the reported pIs for group 1 cephalosporinases (class C) are primarily basic (3), and we have never detected ␤-lactamase activity in that pH range in our IEF gels.
Strain H37Ra and its parent, H37Rv, differ in their susceptibilities to ceftriaxone (MICs, 1 and 16 g/ml, respectively) (6). Since their class A ␤-lactamase sequences are identical at the nucleotide level, alterations in the structure of that enzyme are probably not the cause of the difference. Whether the difference in susceptibility is due to alterations in or overexpression of the class C ␤-lactamase has not been determined.
Nothing is known about the regulation of M. tuberculosis ␤-lactamase production, although it has long been believed to be constitutively produced (17) . Zhang et al. (30) reported that M. tuberculosis ␤-lactamase production is increased after exposure to carbenicillin, but the mechanism responsible for this is unknown.
At the amino acid level, the M. tuberculosis class A ␤-lactamase has 61% homology with that of Mycobacterium fortuitum, 60% homology with that of Streptomyces fradiae, and 62% homology with that of Streptomyces cacaoi (Fig. 1) (7) . It has been shown that the S. cacaoi ␤-lactamase is inducible and that two regulatory genes are located upstream from the ␤-lactamase gene (20, 27) . These two genes encode proteins similar to those identified in cephalosporinase regulatory systems in enterobacteria (19) . A homologous sequence upstream of the M. tuberculosis ␤-lactamase genes would certainly suggest this type of regulation; however, none was found upstream of either the class A or class C ␤-lactamase genes.
The sequence homology between the class A M. tuberculosis ␤-lactamase and the class A ␤-lactamases found in Bacillus licheniformis (60% homology) and Staphylococcus aureus (52% homology) was also striking (Fig. 1) . In these organisms there are two genes (blaI and blaR1) located upstream of the ␤-lactamase gene, and products from both genes are required for the regulated expression of ␤-lactamase (10, 11) . The presence of blaI and blaR1 homologs upstream of the M. tuberculosis ␤-lactamase gene would suggest this type of regulatory mechanism, but again, none was found. It is also possible that ␤-lactamase production in M. tuberculosis is regulated by some as yet unspecified system that does not involve genes directly upstream from the ␤-lactamase gene. However, we have been unable to detect ␤-lactamase induction at all in vitro. This could be because the enzyme is constitutively produced or because the ␤-lactam inducer was not stable over the long incubation time required for growth of M. tuberculosis.
Nucleotide sequence accession number. The nucleotide sequence corresponding to the class A ␤-lactamase sequence reported in this paper has been submitted to the GenBank database and has accession number U67924.
